glutathione production in cancer cells Human cancer-associated fibroblasts enhance levels and antagonize drug-induced prostate cell death Glutathione-mediated nanomedicines for cancer diagnosis

Farag, M

This ability opens up possibilities for tissue engineering, where iPSC-derived cells can be used to replace damaged or dysfunctional cells in various organs [23]

However, further research, particularly clinical trials in humans with specific digestive disorders, is needed to validate these mechanisms and evaluate NMN's efficacy and safety in clinical settings

A variety of pathological factors, including genetics, viral infection, pregnancy, autoimmunity, and drugs, are considered to contribute to the pathogenesis of FT1DM [7], but the specific mechanism of the disease remains largely unknown

KebirHKreymborgKIferganIDodelet-DevillersACayrolRBernardMet alHuman TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation